InsiderClue
Insiders · Profile

SCHIERMEIER ANDREW

EVP, Chief Operating Officer at Intellia Therapeutics. Filing since 6 Mar 2019. CIK 0001738456

Company
Date
Role
Action
Shares
Amount
Of holding
NTLA Intellia Therapeutics, Inc.
5 Jan 2021
EVP, Chief Operating Officer
Sold, plan not stated
1,377
$76.92K
7.6%
NTLA Intellia Therapeutics, Inc.
6 Mar 2019
EVP, Dev and Corp Strategy
Bought
7,500
$117.88K
opened
2 decisions on file.